CERS5 and neoplasm: As shown in Fig. 1d, the TRH4 peptide was also presented by MC38 and GL261 tumor cells incubated with Nucl-TAP, consistent with the hypothesis that new epitopes presented upon TAP downregulation could function as shared, non-mutated clonal neoantigens.